874 results on '"BOGUNIEWICZ, Mark"'
Search Results
2. Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review
3. Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus
4. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations
5. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
6. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
7. The role of Janus kinase signaling in the pathology of atopic dermatitis
8. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
9. Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry
10. List Of Contributors
11. Atopic and Contact Dermatitis
12. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
13. Adverse reactions to antibiotics : is the patient really allergic?
14. Atopic Dermatitis Yardstick update
15. Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin
16. Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology
17. Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis
18. Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
19. Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
20. Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE
21. Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16
22. Contributors
23. Atopic Dermatitis and Allergic Contact Dermatitis
24. 563 - Dupilumab improves skin lipid composition in atopic dermatitis irrespective of patient filaggrin (FLG) mutation status
25. Tapinarof Cream 1% Once Daily: Consistent Efficacy Across Disease Severity And Age Subgroups In The Treatment Of Adults And Children Down To 2 Years Of Age With Moderate To Severe Atopic Dermatitis
26. 548 - Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities
27. Dupilumab Consistently Reduces CCL-17 (TARC) in Patients with Atopic Dermatitis Across All Age Groups
28. 505 - Once-daily roflumilast cream 0.15% for atopic dermatitis: pooled results from INTEGUMENT-1/2 phase 3 trials
29. 533 - Long-term 5-year safety of upadacitinib in moderate-to-severe atopic dermatitis: an integrated analysis including over 7000 patient-years of exposure
30. Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
31. Cutaneous Ceramide Synthase 1 (CERS1) Gene Expression is a Biomarker of Staphylococcus aureus Abundance and Severity of Atopic Dermatitis
32. Topical Treatments for Atopic Dermatitis: Systematic Review and Network Meta-Analysis of Randomized Trials
33. Lebrikizumab Maintains Improvements in the Patient-Oriented Eczema Measure Through 2 Years of Treatment in Patients With Moderate-to-Severe Atopic Dermatitis
34. Systemic Treatments for Atopic Dermatitis: Systematic Review and Network Meta-Analysis of Randomized Trials
35. 562 - Dupilumab treatment provides long-term improvement in itch in pediatric patients with moderate-to-severe atopic dermatitis over 1 year
36. Tralokinumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 years and Older With and Without Atopic Comorbidities
37. Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis
38. The infectious complications of atopic dermatitis
39. Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis.
40. Biologics for Atopic Dermatitis
41. Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial
42. Study of the Atopic March: Development of Atopic Comorbidities
43. Tapinarof Validates the Aryl Hydrocarbon Receptor as a Therapeutic Target: A Clinical Review
44. 680 - Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials.
45. Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults
46. Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults
47. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial
48. Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
49. Atopic Dermatitis in US Adults: From Population to Health Care Utilization
50. Health Utility Scores of Atopic Dermatitis in US Adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.